Anthony Bihl

Anthony P.
Bihl is currently Chairman at Sonendo, Inc. since 2020 and Director at The Arthritis Foundation.
Former roles include CEO of Siemens Medical Solutions Diagnostics in 2007 at Bayer Healthcare LLC and Siemens Medical Solutions Diagnostics, Inc.; Chief Executive Officer & Director at Bioventus LLC and Bioventus, Inc. from 2015 to 2020; President, Chief Executive Officer & Director at Bioventus, Inc. from 2023 to 2024; Chairman at Nuvectra Corp.
from 2019 to 2020; Independent Director at Meridian Bioscience, Inc. from 2020 to 2023 and Integer Holdings Corp.
from 2011 to 2016; Director at SeraCare Life Sciences, Inc., Flowonix Medical, Inc. from 2020 to 2022, Adnavance Technologies, Inc., Greatbatch, Inc. from 2011 to 2016, and Spectral Medical, Inc. in 2024; President at Endo Health Solutions, Inc.; Group President at Astora Women's Health, Inc. from 2011 to 2012; Vice President-Finance & Controlling at Bayer Diagnostics Corp.
in 2002; and President at American Medical Systems, Inc. from 2011 to 2012.
Education includes undergraduate studies at The Pennsylvania State University.